Landfar Bio-medicine Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -64.12% vs 945.60% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -47.64% vs 94.50% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "119.30",
          "val2": "332.50",
          "chgp": "-64.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.70",
          "val2": "17.60",
          "chgp": "-33.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.40",
          "val2": "1.90",
          "chgp": "26.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11.10",
          "val2": "21.20",
          "chgp": "-47.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "98.50%",
          "val2": "17.90%",
          "chgp": "8.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 209.59% vs -1.55% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 175.73% vs 48.93% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "413.30",
          "val2": "133.50",
          "chgp": "209.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28.70",
          "val2": "-8.10",
          "chgp": "454.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.80",
          "val2": "1.80",
          "chgp": "55.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "18.10",
          "val2": "-23.90",
          "chgp": "175.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6.30%",
          "val2": "-194.40%",
          "chgp": "18.81%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

119.30

332.50

-64.12%

Operating Profit (PBDIT) excl Other Income

11.70

17.60

-33.52%

Interest

2.40

1.90

26.32%

Exceptional Items

0.00

-0.00

Consolidate Net Profit

11.10

21.20

-47.64%

Operating Profit Margin (Excl OI)

98.50%

17.90%

8.06%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -64.12% vs 945.60% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -47.64% vs 94.50% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

413.30

133.50

209.59%

Operating Profit (PBDIT) excl Other Income

28.70

-8.10

454.32%

Interest

2.80

1.80

55.56%

Exceptional Items

-0.20

-0.00

Consolidate Net Profit

18.10

-23.90

175.73%

Operating Profit Margin (Excl OI)

-6.30%

-194.40%

18.81%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 209.59% vs -1.55% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 175.73% vs 48.93% in Dec 2024

All Annual Results